Literature DB >> 7977482

Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate.

T Niwa1, M Ise, T Miyazaki.   

Abstract

In uremia there is a marked elevation of serum levels of indoxyl sulfate due to its decreased renal clearance. Indoxyl sulfate is synthesized in the liver from indole which is produced by bacteria in the intestines. To determine the role of indoxyl sulfate in the progression of chronic renal failure, we administered indole, the precursor of indoxyl sulfate, to subtotally nephrectomized uremic rats. The oral administration of indole increased the serum levels of creatinine and blood urea nitrogen and decreased creatinine, inulin, and p-aminohippuric acid clearances. The glomerular sclerosis index in the indole-treated rats was higher than in the control uremic rats. After oral administration, indole could not be detected in the urine, but large amounts of its metabolite, indoxyl sulfate. Thus, indole administration stimulated glomerular sclerosis in a uremic model through the production of indoxyl sulfate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977482     DOI: 10.1159/000168716

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  28 in total

1.  Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate.

Authors:  E Banoglu; G G Jha; R S King
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Oct-Dec       Impact factor: 2.441

2.  Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake.

Authors:  Masaru Motojima; Atsuko Hosokawa; Hideyuki Yamato; Takamura Muraki; Toshimasa Yoshioka
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  Methionine restriction delays senescence and suppresses the senescence-associated secretory phenotype in the kidney through endogenous hydrogen sulfide.

Authors:  Si-Yang Wang; Wen-Juan Wang; Jie-Qiong Liu; Yu-Huan Song; Ping Li; Xue-Feng Sun; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Cell Cycle       Date:  2019-06-05       Impact factor: 4.534

Review 4.  An update on uremic toxins.

Authors:  N Neirynck; R Vanholder; E Schepers; S Eloot; A Pletinck; G Glorieux
Journal:  Int Urol Nephrol       Date:  2012-08-15       Impact factor: 2.370

5.  Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin.

Authors:  Shunsuke Ito; Mizuko Osaka; Yusuke Higuchi; Fuyuhiko Nishijima; Hideto Ishii; Masayuki Yoshida
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

6.  Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota.

Authors:  A Sloan Devlin; Angela Marcobal; Dylan Dodd; Stephen Nayfach; Natalie Plummer; Tim Meyer; Katherine S Pollard; Justin L Sonnenburg; Michael A Fischbach
Journal:  Cell Host Microbe       Date:  2016-12-01       Impact factor: 21.023

7.  Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.

Authors:  Yoshiharu Itoh; Atsuko Ezawa; Kaori Kikuchi; Yoshinari Tsuruta; Toshimitsu Niwa
Journal:  Mass Spectrom (Tokyo)       Date:  2013-04-15

8.  Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate.

Authors:  E Banoglu; R S King
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Apr-Jun       Impact factor: 2.441

9.  Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB.

Authors:  Dilinaer Bolati; Hidehisa Shimizu; Maimaiti Yisireyili; Fuyuhiko Nishijima; Toshimitsu Niwa
Journal:  BMC Nephrol       Date:  2013-03-04       Impact factor: 2.388

Review 10.  What is new in uremic toxicity?

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.